NYSE: ARNA - Arena Pharmaceuticals, Inc.

Yield per half year: -6.03%
Sector: Healthcare

Arena Pharmaceuticals, Inc.

Underestimation
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 61.12 -100% -15.75 -100%
P/S 112540 4.09 2750735.09%
P/BV 9.16 9.64 -4.95%
P/FCF -11.8 52.09 -122.65%
Ev/Ebitda 0.3315 17.28 -98.08%
Ev/S 52.4 4.4 1090.73%
Ev/FCF 0.3507 58.35 -99.4%
E/P -0.0999 0.0339 -394.95%
Efficiency
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-1.01 20.69 -104.88% -247134.71 -100%
ROE -70.3 -89.27 -21.25%
ROA -62.41 6.91 -1002.71%
ROIC 0 12.56 -100%
ROS 17611.43 10.78 163286.18%
ROCE -77.52 13.91 -657.26%
Debt
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.0745 2.89 -102.58% -0.0813 -8.33%
Nеt Debt/Ebitda 0.3316 3.67 -90.96%
Debt/Ratio 0.0525 0.2751 -80.92%
Debt/Equity 2.16 5.17 -58.29%
Debt/Net Income -0.0668 6.84 -100.98%
Dividends
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.5894 -100% 0 0%
Number of years of dividend growth 0 0 0%
DSI 0 0 0%
Average dividend growth 0 0 0%
Average percentage for 5 years 0 0 0%
Average percentage for payments 0 80.02 -100%
Difference from average difference in sector -1.5894 0 0%
Growth impulse
Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue 5 years
0/10
-119.44 -28.88 313.57%
Growth impulse Ebitda 5 years 324.81 -79.88 -506.62%
Growth impulse Net Income 5 years 1996.6 -75.91 -2730.22%
Growth impulse FCF 5 years 293.53 -81.48 -460.25%
Growth impulse EPS 5 years 1506.4 -56.51 -2765.72%
IP Score
4.6/10

Similar companies

PFIZER

Humana

AbbVie

UnitedHealth Group